{"nct_id":"NCT02533453","title":"A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients.","status":"COMPLETED","status_verified_date":"2019-02","start_date":"2016-01-28","start_date_type":"ACTUAL","primary_completion_date":"2016-12-07","primary_completion_date_type":"ACTUAL","completion_date":"2016-12-07","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["AZN"]}